Global Non-Small Cell Lung Cancer Market Assessment, By Type [Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Others], By Treatment Type [Chemotherapy, Targeted Therapy, Immunotherapy], By Drug Class [Angiogenesis Inhibitor, Epidermal Growth Factor Receptor Blocker, Kinase Inhibitor, Microtubule Stabilizer, Folate Antimetabolites, PD-1/PD-L1 Inhibitor], By Distribution Channel [Hospital Pharmacy, Drug Store & Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2016-2030F

Global non-small cell lung cancer market size was valued at USD 10.6 billion in 2022, and is expected to reach USD 21.9 billion in 2030, with a CAGR of 9.5% for the forecast period between 2023 and 2030F. 

Non-Small Cell Lung Cancer Market Size, Share, Growth & Forecast 2031

Global Non-Small Cell Lung Cancer Market Assessment, Opportunities and Forecast, 2016-2030F

Global non-small cell lung cancer market size was valued at USD 10.6 billion in 2022, and is expected to reach USD 21.9 billion in 2030, with a CAGR of 9.5% for the forecast period between 2023 and 2030F.

FAQs

Industry Reports

Blogs

Case Studies

News

Press Release

Infographics